The Impact of Using Triclosan-antibacterial Sutures on the Incidence of Surgical Site Infection

NCT01019447 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 701

Last updated 2011-06-22

No results posted yet for this study

Summary

To compare conventional polyglactin 910 sutures with triclosan-coated polyglactin 910 antimicrobial sutures for the reduction of surgical site infections and any associated health and economic benefits.

Conditions

  • Surgical Site Infection

Interventions

OTHER

Vicryl Plus

Triclosan-coated polyglactin 910 antimicrobial sutures (Vicryl Plus)

OTHER

Vicryl

Polyglactin 910 antimicrobial sutures (Vicryl)

Sponsors & Collaborators

  • Amygate Healthcare

    collaborator UNKNOWN
  • Cairo University

    lead OTHER

Principal Investigators

  • Ibrahim Ga Ibrahim, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01019447 on ClinicalTrials.gov